Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sigma-Genosys

1987 FOUNDED
M&A STATUS
Buyout/LBO LATEST DEAL TYPE
7 FINANCING ROUNDS
Description

Developer of synthetic DNA and peptides. The company is engaged in the development and supply of oligonucleotides, gene arrays, synthetic peptides, genes and research reagents for life science research at pharmaceutical and biotechnology companies, universities and clinical laboratories.

Formerly Known As
Genosys Biotechnologies, Genetic Design
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Primary Office
  • 1442 Lake Front Circle
  • Suite 185
  • The Woodlands, TX 77380
  • United States

Sigma-Genosys Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Sigma-Genosys‘s full profile, request access.

Request full access to PitchBook

Sigma-Genosys Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Sigma-Genosys‘s full profile, request access.

Request full access to PitchBook